glutathione mutations in sclc patients Depletion and Stalwart Anticancer Activity of Metallotherapeutics Inducing Programmed Cell Death: Opening a New Window for Cancer Therapy Frontiers | Targeting lung cancer:

Frontiers Targeting lung cancer: synergistic therapeutic strategy of cuproptosis and immunogenic cell death Frontiers Metabolic reprogramming in lung cancer and its clinical implication NRF2 supports non small cell lung cancer growth independently of CBP p300 enhanced glutathione synthesis EMBO Reports Springer Nature Link The role of ERBB4 mutations in the prognosis of advanced non small cell lung cancer treated with immune checkpoint inhibitors Molecular Medicine Springer Nature Link Genetic variation in glutathione metabolism and DNA repair genes predicts survival of small cell lung cancer patients Annals of Oncology Tumor suppressor genes and KRAS G12C inhibitor resistance in non small cell lung cancer: iScience

SKU: 12706168281 · From condeoeiras.edu.pt